申请人:DSO "Pharmachim"
公开号:US04290971A1
公开(公告)日:1981-09-22
A process for preparing compounds of the formula: ##STR1## or pharmaceutically acceptable salts thereof, wherein R.sub.1 and R.sub.2 each individually are hydrogen, halogen, or nitro, which comprises the steps of: (a) alkylating a compound of the formula: ##STR2## wherein R.sub.3 is C.sub.1 to C.sub.4 alkyl or phenyl, with a compound of the formula: R.sub.4 --X wherein R.sub.4 is C.sub.1 to C.sub.6 alkyl or phenyl-alkyl where the alkyl is C.sub.1 to C.sub.4 and X is halogen, in the presence of a base to yield a compound of the formula: ##STR3## and; (b) cyclizing the compound formed during step (a) with ethylenediamine mono-p-toluenesulphonate at a temperature of 100.degree. to 200.degree. C. to yield the desired product. New intermediate compounds are also disclosed. The desired products have antihypertensive properties.
制备式为:##STR1## 或其药学上可接受的盐的化合物的方法,其中R.sub.1和R.sub.2各自独立地为氢、卤素或硝基,包括以下步骤:(a)用式为:##STR2##其中R.sub.3为C.sub.1至C.sub.4烷基或苯基,与式为:R.sub.4 --X的化合物进行烷基化反应,其中R.sub.4为C.sub.1至C.sub.6烷基或苯基-烷基,烷基为C.sub.1至C.sub.4,X为卤素,在碱存在下得到式为:##STR3##的化合物;(b)将步骤(a)中形成的化合物与乙二胺单-p-甲苯磺酸盐在100℃至200℃的温度下环化,得到所需的产物。还公开了新的中间体化合物。所得的产物具有降压作用。